| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.32B | +7.7% |
| Cost of Revenue | $444.2M | +0.0% |
| Gross Profit | $1.88B | +9.7% |
| R&D Expense | $891.9M | +18.0% |
| SG&A Expense | $222.9M | -0.8% |
| Operating Income | $181.3M | -33.9% |
| Pre-tax Income | $192.7M | -35.6% |
| Income Tax | -$360.5M | -887.7% |
| Net Income | $553.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $232.8M | -56.3% |
| Accounts Receivable | $53.8M | +8.5% |
| Current Assets | $1.49B | -19.5% |
| Total Assets | $3.11B | +0.6% |
| Current Liabilities | $1.20B | +1.8% |
| Total Liabilities | $3.42B | +1.0% |
| Stockholders' Equity | -$309.4M | -5.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $797.3M | +9.2% |
| Capital Expenditures | $33.8M | +52.9% |
| Investing Cash Flow | -$48.5M | +90.8% |
| Financing Cash Flow | -$1.04B | -6530.9% |
| Free Cash Flow | $763.5M | +7.9% |
| +64.7% |
| EPS (Basic) | $1.53 | +75.9% |
| EPS (Diluted) | $1.52 | +78.8% |